CONTINEUM THERAPEUTICS INC-A (CTNM) Stock Cash Flow
NASDAQ:CTNM - Nasdaq - US21217B1008 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | |||||||
| Net Income | -42.26M | 22.72M | -24.25M | -29.00M | |||
| Depreciation Amortization | 258.00K | 195.00K | 329.00K | 325.00K | |||
| Change In Working Capital | 5.33M | -1.02M | -1.27M | 108.00K | |||
| Interest Paid | 0.00 | 150.00K | 225.00K | 225.00K | |||
| Taxes Paid | 0.00 | 450.00K | N/A | N/A | |||
| Other non cash items | 3.82M | -2.54M | 5.07M | 2.30M | |||
| OPERATING CASH FLOW | -32.84M | 19.35M | -20.12M | -26.27M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | |||||||
| Capital Expenditure | -514.00K | -414.00K | -118.00K | -168.00K | |||
| Other Investing Activity | -69.22M | -65.15M | 22.42M | -64.80M | |||
| INVESTING CASH FLOW | -69.74M | -65.57M | 22.30M | -64.97M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | |||||||
| Debt Issued/Reduced | 0.00 | -3.75M | -1.25M | 0.00 | |||
| Stock Issued/Repurchased | 109.00M | 60.30M | 15.00K | 79.74M | |||
| Other Financing Activity | 0.00 | -371.00K | -4.00K | 96.00K | |||
| FINANCING CASH FLOW | 109.00M | 56.18M | -1.24M | 79.84M | |||
| CHANGE IN CASH | 6.42M | 9.96M | 939.00K | -11.39M | |||
| FREE CASH FLOW | |||||||
| Operating Cash Flow | -32.84M | 19.35M | -20.12M | -26.27M | |||
| Capital Expenditure | -514.00K | -414.00K | -118.00K | -168.00K | |||
| FREE CASH FLOW | -33.36M | 18.93M | -20.24M | -26.43M | |||
All data in USD